Authors: PASS HW TEMECK BK KRANDA K STEINBERG SM PASS HI

Citation: Hw. Pass et al., A PHASE-II TRIAL INVESTIGATING PRIMARY IMMUNOCHEMOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA AND THE FEASIBILITY OF ADJUVANT IMMUNOCHEMOTHERAPY AFTER MAXIMAL CYTOREDUCTION, Annals of surgical oncology, 2(3), 1995, pp. 214-220